Webinar recording
Indications for Hormone Testing with Mira in Perimenopause
This webinar discusses how urinary hormone tracking with Mira can support perimenopausal care—helping providers assess ovulatory patterns, identify hormonal shifts, and tailor HRT strategies using real patient cases and cycle charts.

Unopposed estrogen in an anovulatory cycle in perimenopause
Have you had a patient who initially responded well to BHRT or other interventions, only to develop new or worsening symptoms after previously being stable? In situations like this, real-time insight into hormonal changes can be key—especially as endogenous hormone patterns may shift dramatically during the menopausal transition.
In this case, a patient initially presented with average E3G levels, but real-time monitoring revealed a rapid progression to excessive E3G without ovulation—something that would have been missed with one-time serum estradiol testing. This case validated the patient’s symptoms and helped guide timely clinical decision-making.

At-home hormone monitoring
for improved, personalized care
Welcome to Mira! Follow the steps below to receive your join our provider partnership program.

Claim your Mira sample after the meeting with our Clinical team
Watch the video to learn more about our trial process.
Choose a partnership that fits your practice
Offer your patients exclusive discounts on Mira products, with or without earning commissions for referrals. Watch the video to explore our partnership options (Affiliate, Dropshipping, and Bulk Purchase) and sign up below to the model that fits your clinical approach best.


